This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Yang G, Ge S, Singh R, Basu S, Shatzer K, Zen M, Liu J, Tu Y, Zhang C, Wei J, Shi J, Zhu L, Liu Z, Wang Y, Gao S, Hu M. Glucuronidation: driving factors and their impact on glucuronide disposition. Drug Metab Rev 2017;49:105–38. doi: 10.1080/03602532.2017.1293682YangGGeSSinghRBasuSShatzerKZenMLiuJTuYZhangCWeiJShiJZhuLLiuZWangYGaoSHuMGlucuronidation: driving factors and their impact on glucuronide dispositionDrug Metab Rev2017491053810.1080/03602532.2017.1293682Open DOISearch in Google Scholar
Lv X, Zhang J-B, Hou J, Dou T-Y, Ge G-B, Hu W-Z, Yang L. Chemical probes for human UDP-glucuronosyltransferases: a comprehensive review. Biotechnol J 2019;14(1):1800002. doi: 10.1002/biot.201800002LvXZhangJ-BHouJDouT-YGeG-BHuW-ZYangLChemical probes for human UDP-glucuronosyltransferases: a comprehensive reviewBiotechnol J2019141180000210.1002/biot.201800002Open DOISearch in Google Scholar
Rowland A, Min e rs JO, Mackenzie PI. The UDP-glucuronosyltransferases: their role in drug metabolism and detoxification. Int J Biochem Cell Biol 2013;45:1121–32. doi: 10.1016/j.biocel.2013.02.019RowlandAMin e rs JO, Mackenzie PI. The UDP-glucuronosyltransferases: their role in drug metabolism and detoxificationInt J Biochem Cell Biol20134511213210.1016/j.biocel.2013.02.019Open DOISearch in Google Scholar
Kasteel EEJ, Darney K, Kramer NI, Dorne JLCM, Lautz LS. Human variability in isoform-specific UDP-glucuronosyltransferases: markers of acute and chronic exposure, polymorphisms and uncertainty factors. Arch Toxicol 2020;94:2637–61. doi: 10.1007/s00204-020-02765-8KasteelEEJDarneyKKramerNIDorneJLCMLautzLSHuman variability in isoform-specific UDP-glucuronosyltransferases: markers of acute and chronic exposure, polymorphisms and uncertainty factorsArch Toxicol20209426376110.1007/s00204-020-02765-8Open DOISearch in Google Scholar
Williams JA, Hyland R, Jones BC, Smith DA, Hurst S, Goosen TC, Peterkin V, Koup JR, Ball SE. Drug-drug interactions for UDP-glucuronosyltransferase substrates: a pharmacokinetic explanation for typically observed low exposure (AUCi/AUC) ratios. Drug Metab Dispos 2004;32:1201–8. doi: 10.1124/dmd.104.000794WilliamsJAHylandRJonesBCSmithDAHurstSGoosenTCPeterkinVKoupJRBallSEDrug-drug interactions for UDP-glucuronosyltransferase substrates: a pharmacokinetic explanation for typically observed low exposure (AUCi/AUC) ratiosDrug Metab Dispos2004321201810.1124/dmd.104.000794Open DOISearch in Google Scholar
Kilpatrick GJ, Smith TW. Morphine-6-glucuronide: actions and mechanisms. Med Res Rev 2005;25:521–44. doi: 10.1002/med.20035KilpatrickGJSmithTWMorphine-6-glucuronide: actions and mechanismsMed Res Rev2005255214410.1002/med.20035Open DOISearch in Google Scholar
Dong D, Ako R, Hu M, Wu B. Understanding substrate selectivity of human UDP-glucuronosyltransferases through QSAR modeling and analysis of homologous enzymes. Xenobiotica 2012;42:808–20. doi: 10.3109/00498254.2012.663515DongDAkoRHuMWuBUnderstanding substrate selectivity of human UDP-glucuronosyltransferases through QSAR modeling and analysis of homologous enzymesXenobiotica2012428082010.3109/00498254.2012.663515Open DOISearch in Google Scholar
Stingl JC, Bartels H, Viviani R, Lehmann ML, Brockmöller J. Relevance of UDP-glucuronosyltransferase polymorphisms for drug dosing: a quantitative systematic review. Pharmacol Ther 2014;141:92–116. doi: 10.1016/j.pharmthera.2013.09.002StinglJCBartelsHVivianiRLehmannMLBrockmöllerJRelevance of UDP-glucuronosyltransferase polymorphisms for drug dosing: a quantitative systematic reviewPharmacol Ther20141419211610.1016/j.pharmthera.2013.09.002Open DOISearch in Google Scholar
Kiang TKL, Ensom MHH, Chang TKH. UDP-glucuronosyltransferases and clinical drug-drug interactions. Pharmacol Ther 2005;106:97–132. doi: 10.1016/j.pharmthera.2004.10.013KiangTKLEnsomMHHChangTKHUDP-glucuronosyltransferases and clinical drug-drug interactionsPharmacol Ther20051069713210.1016/j.pharmthera.2004.10.013Open DOISearch in Google Scholar
Zucker K, Rosen A, Tsaroucha A, de Faria L, Roth D, Ciancio G, Esquenazi V, Burke G, Tzakis A, Miller J. Unexpected augmentation of mycophenolic acid pharmacokinetics in renal transplant patients receiving tacrolimus and mycophenolate mofetil in combination therapy, and analogous in vitro findings. Transpl Immunol 1997;5:225– 32. doi: 10.1016/s0966-3274(97)80042-1ZuckerKRosenATsarouchaAde FariaLRothDCiancioGEsquenaziVBurkeGTzakisAMillerJUnexpected augmentation of mycophenolic acid pharmacokinetics in renal transplant patients receiving tacrolimus and mycophenolate mofetil in combination therapy, and analogous in vitro findingsTranspl Immunol199752253210.1016/s0966-3274(97)80042-1Open DOISearch in Google Scholar
Wang P, Lin X-Q, Cai W-K Xu G-L, Zhou M-D, Yang M, He G-H. Effect of UGT2B7 genotypes on plasma concentration of valproic acid: a meta-analysis. Eur J Clin Pharmacol 2018;74:433–42. doi: 10.1007/s00228-017-2395-zWangPLinX-QCaiW-KXuG-LZhouM-DYangMHeG-HEffect of UGT2B7 genotypes on plasma concentration of valproic acid: a meta-analysisEur J Clin Pharmacol2018744334210.1007/s00228-017-2395-zOpen DOISearch in Google Scholar
Shen ML, Xiao A, Yin SJ, Wang P, Lin XQ, Yu CB, He GH. Associations between UGT2B7 polymorphisms and cancer susceptibility: a meta-analysis. Gene 2019;706:115–23. doi: 10.1016/j. gene.2019.05.025ShenMLXiaoAYinSJWangPLinXQYuCBHeGHAssociations between UGT2B7 polymorphisms and cancer susceptibility: a meta-analysisGene20197061152310.1016/j.gene.2019.05.025Open DOISearch in Google Scholar
Coffman BL, King CD, Rios GR, Tephly TR. The glucuronidation of opioids, other xenobiotics, and androgens by human UGT2B7Y(268) and UGT2B7H(268). Drug Metab Dispos 1998;26:73–7. PMID: 9443856CoffmanBLKingCDRiosGRTephlyTRThe glucuronidation of opioids, other xenobiotics, and androgens by human UGT2B7Y(268) and UGT2B7H(268)Drug Metab Dispos199826737PMID: 9443856Search in Google Scholar
Bélanger A-S, Caron P, Harvey M, Zimmerman PA, Mehlotra RK, Guillemette C. Glucuronidation of the antiretroviral drug efavirenz by UGT2B7 and an in vitro investigation of drug-drug interaction with zidovudine. Drug Metab Dispos 2009;37:1793–6. doi: 10.1124/ dmd.109.027706BélangerA-SCaronPHarveyMZimmermanPAMehlotraRKGuillemetteCGlucuronidation of the antiretroviral drug efavirenz by UGT2B7 and an in vitro investigation of drug-drug interaction with zidovudineDrug Metab Dispos2009371793610.1124/dmd.109.027706Open DOISearch in Google Scholar
Barbier O, Turgeon D, Girard C, Green MD, Tephly TR, Hum DW, Bélanger A. 3’-azido-3’-deoxythimidine (AZT) is glucuronidated by human UDP-glucuronosyltransferase 2B7 (UGT2B7). Drug Metab Dispos 2000;28:497–502. PMID: 10772627BarbierOTurgeonDGirardCGreenMDTephlyTRHumDWBélangerA3’-azido-3’-deoxythimidine (AZT) is glucuronidated by human UDP-glucuronosyltransferase 2B7 (UGT2B7)Drug Metab Dispos200028497502PMID: 10772627Search in Google Scholar
Wang H, Yuan L, Zeng S. Characterizing the effect of UDP-glucuronosyltransferase (UGT) 2B7 and UGT1A9 genetic polymorphisms on enantioselective glucuronidation of flurbiprofen. Biochem Pharmacol 2011;82:1757–63. doi: 10.1016/j.bcp.2011.08.004WangHYuanLZengSCharacterizing the effect of UDP-glucuronosyltransferase (UGT) 2B7 and UGT1A9 genetic polymorphisms on enantioselective glucuronidation of flurbiprofenBiochem Pharmacol20118217576310.1016/j.bcp.2011.08.004Open DOISearch in Google Scholar
Duguay Y, Báár C, Skorpen F, Guillemette C. A novel functional polymorphism in the uridine diphosphate-glucuronosyltransferase 2B7 promoter with significant impact on promoter activity. Clin Pharmacol Ther 2004;75:223–33. doi: 10.1016/j.clpt.2003.10.006DuguayYBáárCSkorpenFGuillemetteCA novel functional polymorphism in the uridine diphosphate-glucuronosyltransferase 2B7 promoter with significant impact on promoter activityClin Pharmacol Ther2004752233310.1016/j.clpt.2003.10.006Open DOISearch in Google Scholar
Thibaudeau J, Lépine J, Tojcic J, Duguay Y, Pelletier G, Plante M, Brisson J, Têtu B, Jacob S, Perusse L, Bélanger A, Guillemette C. Characterization of common UGT1A8, UGT1A9, and UGT2B7 variants with different capacities to inactivate mutagenic 4-hydroxylated metabolites of estradiol and estrone. Cancer Res 2006;66:125–33. doi: 10.1158/0008-5472.CAN-05-2857ThibaudeauJLépineJTojcicJDuguayYPelletierGPlanteMBrissonJTêtuBJacobSPerusseLBélangerAGuillemetteCCharacterization of common UGT1A8, UGT1A9, and UGT2B7 variants with different capacities to inactivate mutagenic 4-hydroxylated metabolites of estradiol and estroneCancer Res2006661253310.1158/0008-5472.CAN-05-2857Open DOISearch in Google Scholar
Meech R, Hu DG, McKinnon RA, Mubarokah SN, Haines AZ, Nair PC, Rowland A, Mackenzie PI. The UDP-glycosyltransferase (UGT) superfamily: new members, new functions, and novel paradigms. Physiol Rev 2019;99:1153–22. doi: 10.1152/physrev.00058.2017MeechRHuDGMcKinnonRAMubarokahSNHainesAZNairPCRowlandAMackenziePIThe UDP-glycosyltransferase (UGT) superfamily: new members, new functions, and novel paradigmsPhysiol Rev20199911532210.1152/physrev.00058.2017Open DOISearch in Google Scholar
Jarrar YB, Cha E-Y, Seo K-A, Ghim JL, Kim HJ, Kim DH, Lee SJ, Shin JG. Determination of major UDP-glucuronosyltransferase enzymes and their genotypes responsible for 20-HETE glucuronidation. J Lipid Res 2014;55:2334–42. doi: 10.1194/jlr.M051169JarrarYBChaE-YSeoK-AGhimJLKimHJKimDHLeeSJShinJGDetermination of major UDP-glucuronosyltransferase enzymes and their genotypes responsible for 20-HETE glucuronidationJ Lipid Res20145523344210.1194/jlr.M051169Open DOISearch in Google Scholar
Božina N, Ganoci L, Simičević L, Gvozdanović K, Domjanović IK, Fistrek Prlić M, Križ T, Borić Bilušić A, Laganović M, Božina T. Drug-drug-gene interactions as mediators of adverse drug reactions to diclofenac and statins: a case report and literature review. Arh Hig Rada Toksikol 2021;72:114–28. doi: 10.2478/aiht-2021-72-3549BožinaNGanociLSimičevićLGvozdanovićKDomjanovićIKFistrek PrlićMKrižTBorić BilušićALaganovićMBožinaTDrug-drug-gene interactions as mediators of adverse drug reactions to diclofenac and statins: a case report and literature reviewArh Hig Rada Toksikol2021721142810.2478/aiht-2021-72-3549Open DOISearch in Google Scholar
Sastre JA, Varela G, López M, Muriel C, González-Sarmiento R. Influence of uridine diphosphate-glucuronyltransferase 2B7 (UGT2B7) variants on postoperative buprenorphine analgesia. Pain Pract 2015;15:22–30. doi: 10.1111/papr.12152SastreJAVarelaGLópezMMurielCGonzález-SarmientoRInfluence of uridine diphosphate-glucuronyltransferase 2B7 (UGT2B7) variants on postoperative buprenorphine analgesiaPain Pract201515223010.1111/papr.12152Open DOISearch in Google Scholar
Inoue K, Suzuki E, Yazawa R, Yamamoto Y, Takahashi T, Takahashi Y, Imai K, Koyama S, Inoue Y, Tsuji D, Hayashi H, Itoh K. Influence of uridine diphosphate glucuronosyltransferase 2B7 -161C>T polymorphism on the concentration of valproic acid in pediatric epilepsy patients. Ther Drug Monit 2014;36:406–9. doi: 10.1097/ FTD.0000000000000012InoueKSuzukiEYazawaRYamamotoYTakahashiTTakahashiYImaiKKoyamaSInoueYTsujiDHayashiHItohKInfluence of uridine diphosphate glucuronosyltransferase 2B7 -161C>T polymorphism on the concentration of valproic acid in pediatric epilepsy patientsTher Drug Monit201436406910.1097/FTD.0000000000000012Open DOISearch in Google Scholar
Duguay Y, Báár C, Skorpen F, Guillemette C. A novel functional polymorphism in the uridine diphosphateglucuronosyltransferase 2B7 promoter with significant impact on promoter activity. Clin Pharmacol Ther 2004;75:223–33. doi: 10.1016/j.clpt.2003.10.006DuguayYBáárCSkorpenFGuillemetteCA novel functional polymorphism in the uridine diphosphateglucuronosyltransferase 2B7 promoter with significant impact on promoter activityClin Pharmacol Ther2004752233310.1016/j.clpt.2003.10.006Open DOISearch in Google Scholar
Barbier O, Turgeon D, Girard C, Green MD, Tephly TR, Hum DW. 3’-azido-3’-deoxythimidine (AZT) is glucuronidated by human UDP-glucuronosyltransferase 2B7 (UGT2B7). Drug Metab Dispos 2000;28:497–502. PMID: 10772627BarbierOTurgeonDGirardCGreenMDTephlyTRHumDW3’-azido-3’-deoxythimidine (AZT) is glucuronidated by human UDP-glucuronosyltransferase 2B7 (UGT2B7)Drug Metab Dispos200028497502PMID: 10772627Search in Google Scholar
Wang H, Yuan L, Zeng S. Characterizing the effect of UDP glucuronosyltransferase (UGT) 2B7 and UGT1A9 genetic polymorphisms on enantioselective glucuronidation of flurbiprofen. Biochem Pharmacol 2011;82:1757–63. doi: 10.1016/j.bcp.2011.08.004WangHYuanLZengSCharacterizing the effect of UDP glucuronosyltransferase (UGT) 2B7 and UGT1A9 genetic polymorphisms on enantioselective glucuronidation of flurbiprofenBiochem Pharmacol20118217576310.1016/j.bcp.2011.08.004Open DOISearch in Google Scholar
Klarica Domjanović I, Lovrić M, Trkulja V, Petelin-Gadže Ž, Ganoci L, Čajić I, Božina N. Interaction between ABCG2 421C>A polymorphism and valproate in their effects on steady-state disposition of lamotrigine in adults with epilepsy. Br J Clin Pharmacol 2018;84:2106–19. doi: 10.1111/bcp.13646Klarica DomjanovićILovrićMTrkuljaVPetelin-GadžeŽGanociLČajićIBožinaNInteraction between ABCG2 421C>A polymorphism and valproate in their effects on steady-state disposition of lamotrigine in adults with epilepsyBr J Clin Pharmacol20188421061910.1111/bcp.13646Open DOISearch in Google Scholar
Sawyer MB, Innocenti F, Das S, Cheng C, Ramírez J, Pantle-Fisher FH, Wright C, Badner J, Pei D, Boyett JM, Cook E Jr, Ratain MJ. A pharmacogenetic study of uridine diphosphate-glucuronosyltransferase 2B7 in patients receiving morphine. Clin Pharmacol Ther 2003;73:566– 74. doi: 10.1016/S0009-9236(03)00053-5SawyerMBInnocentiFDasSChengCRamírezJPantle-FisherFHWrightCBadnerJPeiDBoyettJMCook EJrRatainMJA pharmacogenetic study of uridine diphosphate-glucuronosyltransferase 2B7 in patients receiving morphineClin Pharmacol Ther2003735667410.1016/S0009-9236(03)00053-5Open DOISearch in Google Scholar
Singkham N, Towanabut S, Lertkachatarn S, Punyawudho B. Influence of the UGT2B7 -161C>T polymorphism on the population pharmacokinetics of lamotrigine in Thai patients. Eur J Clin Pharmacol 2013;69:1285–91. doi: 10.1007/s00228-012-1449-5SingkhamNTowanabutSLertkachatarnSPunyawudhoBInfluence of the UGT2B7 -161C>T polymorphism on the population pharmacokinetics of lamotrigine in Thai patientsEur J Clin Pharmacol20136912859110.1007/s00228-012-1449-5Open DOISearch in Google Scholar
Blanca Sánchez M, Herranz JL, Leno C, Arteaga R, Oterino A, Valdizán EM, Nicolas JM, Adín J, Shushtarian M, Armijo JA. UGT2B7_-161C>T polymorphism is associated with lamotrigine concentration-to-dose ratio in a multivariate study. Ther Drug Monit 2010;32:177–84. doi: 10.1097/FTD.0b013e3181ceecc6Blanca SánchezMHerranzJLLenoCArteagaROterinoAValdizánEMNicolasJMAdínJShushtarianMArmijoJAUGT2B7_-161C>T polymorphism is associated with lamotrigine concentration-to-dose ratio in a multivariate studyTher Drug Monit2010321778410.1097/FTD.0b013e3181ceecc6Open DOISearch in Google Scholar
Milosheska D, Lorber B, Vovk T, Kastelic M, Dolžan V, Grabnar I. Pharmacokinetics of lamotrigine and its metabolite N-2-glucuronide: Influence of polymorphism of UDP-glucuronosyltransferases and drug transporters. Br J Clin Pharmacol 2016;82:399–411. doi: 10.1111/ bcp.12984MilosheskaDLorberBVovkTKastelicMDolžanVGrabnarIPharmacokinetics of lamotrigine and its metabolite N-2-glucuronide: Influence of polymorphism of UDP-glucuronosyltransferases and drug transportersBr J Clin Pharmacol20168239941110.1111/bcp.12984Open DOISearch in Google Scholar
Vrkić Kirhmajer M, Macolić Šarinić V, Šimičević L, Ladić I, Putarek K, Banfić L, Božina N. Rosuvastatin-induced rhabdomyolysis - possible role of ticagrelor and patients’ pharmacogenetic Profile. Basic Clin Pharmacol Toxicol 2018;123:509–18. doi: 10.1111/bcpt.13035Vrkić KirhmajerMMacolić ŠarinićVŠimičevićLLadićIPutarekKBanfićLBožinaNRosuvastatin-induced rhabdomyolysis - possible role of ticagrelor and patients’ pharmacogenetic ProfileBasic Clin Pharmacol Toxicol20181235091810.1111/bcpt.13035Open DOISearch in Google Scholar
Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alföldi J, Wang Q, Collins RL, Laricchia KM, Ganna A, Birnbaum DP, Gauthier LD, Brand H, Solomonson M, Watts NA, Rhodes D, Singer-Berk M, England EM, Seaby EG, Kosmicki JA, Walters RK, Tashman K, Farjoun Y, Banks E, Poterba T, Wang A, Seed C, Whiffin N, Chong JX, Samocha KE, Pierce-Hoffman E, Zappala Z, O’Donnell-Luria AH, Minikel EV, Weisburd B, Lek M, Ware JS, Vittal C, Armean IM, Bergelson L, Cibulskis K, Connolly KM, Covarrubias M, Donnelly S, Ferriera S, Gabriel S, Gentry J, Gupta N, Jeandet T, Kaplan D, Llanwarne C, Munshi R, Novod S, Petrillo N, Roazen D, Ruano-Rubio V, Saltzman A, Schleicher M, Soto J, Tibbetts K, Tolonen C, Wade G, Talkowski ME; Genome Aggregation Database Consortium, Neale BM, Daly MJ, MacArthur DG. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 2020;581:434–43. doi: 10.1038/s41586-020-2308-7KarczewskiKJFrancioliLCTiaoGCummingsBBAlföldiJWangQCollinsRLLaricchiaKMGannaABirnbaumDPGauthierLDBrandHSolomonsonMWattsNARhodesDSinger-BerkMEnglandEMSeabyEGKosmickiJAWaltersRKTashmanKFarjounYBanksEPoterbaTWangASeedCWhiffinNChongJXSamochaKEPierce-HoffmanEZappalaZO’Donnell-LuriaAHMinikelEVWeisburdBLekMWareJSVittalCArmeanIMBergelsonLCibulskisKConnollyKMCovarrubiasMDonnellySFerrieraSGabrielSGentryJGuptaNJeandetTKaplanDLlanwarneCMunshiRNovodSPetrilloNRoazenDRuano-RubioVSaltzmanASchleicherMSotoJTibbettsKTolonenCWadeGTalkowskiMEGenome Aggregation Database ConsortiumNealeBMDalyMJMacArthurDGThe mutational constraint spectrum quantified from variation in 141,456 humansNature20205814344310.1038/s41586-020-2308-7Open DOISearch in Google Scholar
Genome Aggregation Database (gnomAD). UGT2B7 (rs7668258), 2022 [displayed 30 April 2022]. Available at https://gnomad.broadinstitute.org/variant/4-69962078-T-C?dataset=gnomad_r2_1Genome Aggregation Database (gnomAD)UGT2B7 (rs7668258)2022[displayed 30 April 2022]. Available athttps://gnomad.broadinstitute.org/variant/4-69962078-T-C?dataset=gnomad_r2_1Search in Google Scholar
The 1000 Genomes database. UGT2B7 (rs7668258) [displayed 30 April 2022]. Available at http://www.ensembl.org/Homo_sapiens/Variation/Population?db=core;r=4:69095860-69096860;v=rs7668258;vdb=variation;vf=94021737The 1000 Genomes databaseUGT2B7 (rs7668258) [displayed 30 April 2022]Available athttp://www.ensembl.org/Homo_sapiens/Variation/Population?db=core;r=4:69095860-69096860;v=rs7668258;vdb=variation;vf=94021737Search in Google Scholar
Fairley S, Lowy-Gallego E, Perry E, Flicek P. The International Genome Sample Resource (IGSR) collection of open human genomic variation resources. Nucleic Acids Res 2020;48(D1):D941–7. doi: 10.1093/nar/gkz836FairleySLowy-GallegoEPerryEFlicekPThe International Genome Sample Resource (IGSR) collection of open human genomic variation resourcesNucleic Acids Res202048D1D941710.1093/nar/gkz836Open DOISearch in Google Scholar
Bińkowski J MS. Gene-Calc [displayed 22 May 2022]. Available at http://www.gene-calc.plBińkowskiJ MS.Gene-Calc[displayed 22 May 2022]. Available athttp://www.gene-calc.plSearch in Google Scholar
van der Logt EM, te Morsche RH, Groenendaal N, Roelofs HM, de Metz M, van der Stappen JW, Nagengast FM, Peters WH. Genetic polymorphism in UDP-glucuronosyltransferase 2B7 and colorectal c a n c e r risk . On co l R e s 2 0 0 9 ; 1 7 : 3 2 3 – 9 . do i : 10.3727/096504009787721203van der LogtEMte MorscheRHGroenendaalNRoelofsHMde MetzMvan der StappenJWNagengastFMPetersWHGenetic polymorphism in UDP-glucuronosyltransferase 2B7 and colorectal cancer riskOn col Res2009173issue9doi10.3727/096504009787721203Open DOISearch in Google Scholar
Zhao F, Wang X, Wang Y, Zhang J, Lai R, Zhang B, Zhou X. The function of uterine UDP-glucuronosyltransferase 1A8 (UGT1A8) and UDP-glucuronosyltransferase 2B7 (UGT2B7) is involved in endometrial cancer based on estrogen metabolism regulation. Hormones (Athens) 2020;19:403–12. doi: 10.1007/s42000-020-00213-xZhaoFWangXWangYZhangJLaiRZhangBZhouXThe function of uterine UDP-glucuronosyltransferase 1A8 (UGT1A8) and UDP-glucuronosyltransferase 2B7 (UGT2B7) is involved in endometrial cancer based on estrogen metabolism regulationHormones (Athens)2020194031210.1007/s42000-020-00213-xOpen DOISearch in Google Scholar
He B-X, Qiao B, Lam AK-Y, Zhao X-L, Zhang W-Z, Liu H. Association between UDP-glucuronosyltransferase 2B7 tagSNPs and breast cancer risk in Chinese females. Clin Exp Pharmacol Physiol 2018;45:437–43. doi: 10.1111/1440-1681.12908HeB-XQiaoBLamAK-YZhaoX-LZhangW-ZLiuHAssociation between UDP-glucuronosyltransferase 2B7 tagSNPs and breast cancer risk in Chinese femalesClin Exp Pharmacol Physiol2018454374310.1111/1440-1681.12908Open DOISearch in Google Scholar
Lin GF, Guo WC, Chen JG, Qin YQ, Golka K, Xiang CQ, Ma QW, Lu DR, Shen JH. An association of UDP-glucuronosyltransferase 2B7 C802T (His268Tyr) polymorphism with bladder cancer in benzidine-exposed workers in China. Toxicol Sci 2005;85:502–6. doi: 10.1093/toxsci/kfi068LinGFGuoWCChenJGQinYQGolkaKXiangCQMaQWLuDRShenJHAn association of UDP-glucuronosyltransferase 2B7 C802T (His268Tyr) polymorphism with bladder cancer in benzidine-exposed workers in ChinaToxicol Sci200585502610.1093/toxsci/kfi068Open DOISearch in Google Scholar
